Strategic Procurement & Medicines Management ...

Send us Fan MailHow will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models such as GENEROUS, GLOBE, and GUARD mean for launch planning, pricing corridors, and payer expectations worldwid ...  Show more

Send us Fan MailHow do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina, Brazil, Colombia, and Mexico? How do evidence requirements, access rou ...  Show more

The unprecedented challenges we have experienced in planning and delivering all aspects of health and care services during the COVID-19 pandemic have acted as a catalyst for testing innovative, outcome focused approaches. This has brought a new focus to how we deliver safe, perso ...  Show more

Welcome to the Strategy& Insider Podcast. In our first season, we will discuss some of the most fundamental questions about the Future of Health. Our guests are experts across all sectors of the healthcare industry including pharma executives, leading academics and medical physic ...  Show more

In this episode we explore digital health and med tech; learning from the pandemic response; and the future digital health strategy for Wales. Our guest is Ifan Evans, Executive Director of Strategy at Digital Health and Care Wales and previously Director of Digital Technology an ...  Show more

In this episode of Medical Affairs unscripted, Peg Crowley-Nowick, PhD, MBA, Senior Advisor, Medical Affairs Consulting at Lumanity, and Cathy Symonds, PhD, Program Lead and Head of New Product Planning at Arbor Biotechnologies, engage in an insightful discussion about the evolvi ...  Show more